Zobrazuji výsledky 1 - 20 z 27 pro vyhledávání 'Serena Di Cosimo', doba hledání: 0,09 s.
Upřesnit hledání
-
1
-
2
-
3
-
4
-
5
-
6
Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancer Autor Serena Di Cosimo, Marco Silvestri, Cinzia De Marco, Alessia Calzoni, Maria Carmen De Santis, Maria Grazia Carnevale, Carolina Reduzzi, Massimo Cristofanilli, Vera Cappelletti
Vydáno 2024-09-01
Článek -
7
Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma Autor Marco Silvestri, Trung Nghia Vu, Federico Nichetti, Monica Niger, Serena Di Cosimo, Filippo De Braud, Giancarlo Pruneri, Yudi Pawitan, Stefano Calza, Vera Cappelletti
Vydáno 2023-04-01
Článek -
8
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy Autor Alberto Zambelli, Marina Cazzaniga, Nicla La Verde, Elisabetta Munzone, Ippazio Cosimo Antonazzo, Lorenzo Giovanni Mantovani, Serena Di Cosimo, Anna Mancuso, Daniele Generali, Paolo Angelo Cortesi
Vydáno 2023-10-01
Článek -
9
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer Autor Fatima Cardoso, Dario Trapani, Carmen Criscitiello, Giuseppe Curigliano, Evandro de Azambuja, Sibylle Loibl, Suzette Delaloge, Elzbieta Senkus, Philip Poortman, Michael Gnant, Serena Di Cosimo, Javier Cortes, Shani Paluch-Shimon
Vydáno 2020-11-01
Článek -
10
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial Autor Mattia Rediti, David Venet, Andrea Joaquin Garcia, Marion Maetens, Delphine Vincent, Samira Majjaj, Sarra El-Abed, Serena Di Cosimo, Takayuki Ueno, Miguel Izquierdo, Martine Piccart, Lajos Pusztai, Sherene Loi, Roberto Salgado, Giuseppe Viale, Françoise Rothé, Christos Sotiriou
Vydáno 2024-11-01
Článek -
11
A gene expression-based classifier for HER2-low breast cancer Autor Serena Di Cosimo, Sara Pizzamiglio, Chiara Maura Ciniselli, Valeria Duroni, Vera Cappelletti, Loris De Cecco, Cinzia De Marco, Marco Silvestri, Maria Carmen De Santis, Andrea Vingiani, Biagio Paolini, Rosaria Orlandi, Marilena Valeria Iorio, Giancarlo Pruneri, Paolo Verderio
Vydáno 2024-02-01
Článek -
12
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial Autor Tomás Pascual, Mafalda Oliveira, Patricia Villagrasa, Vanesa Ortega, Laia Paré, Begoña Bermejo, Serafín Morales, Kepa Amillano, Rafael López, Patricia Galván, Jordi Canes, Fernando Salvador, Paolo Nuciforo, Isabel T. Rubio, Antonio Llombart-Cussac, Serena Di Cosimo, José Baselga, Nadia Harbeck, Aleix Prat, Javier Cortés
Vydáno 2021-11-01
Článek -
13
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO Autor Serena Di Cosimo, Chiara M. Ciniselli, Sara Pizzamiglio, Vera Cappelletti, Marco Silvestri, Sarra El-Abed, Miguel Izquierdo, Mohammed Bajji, Paolo Nuciforo, Jens Huober, Jens Huober, David Cameron, Stephen Chia, Henry L. Gomez, Henry L. Gomez, Marilena V. Iorio, Andrea Vingiani, Giancarlo Pruneri, Paolo Verderio
Vydáno 2023-01-01
Článek -
14
Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study. Autor Serena Di Cosimo, Nicla La Verde, Anna Moretti, Marina Elena Cazzaniga, Daniele Generali, Giulia Valeria Bianchi, Luigi Mariani, Valter Torri, Flavio Crippa, Biagio Paolini, Gianfranco Scaperrotta, Maria Carmen De Santis, Massimo Di Nicola, Giovanni Apolone, Alessandro Gulino, Claudio Tripodo, Mario Paolo Colombo, Secondo Folli, Filippo de Braud
Vydáno 2019-01-01
Článek -
15
What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study Autor Sara Pizzamiglio, Giulia Cosentino, Chiara M. Ciniselli, Loris De Cecco, Alessandra Cataldo, Ilaria Plantamura, Tiziana Triulzi, Sarra El‐abed, Yingbo Wang, Mohammed Bajji, Paolo Nuciforo, Jens Huober, Susan L. Ellard, David L. Rimm, Andrea Gombos, Maria Grazia Daidone, Paolo Verderio, Elda Tagliabue, Serena Di Cosimo, Marilena V. Iorio
Vydáno 2022-01-01
Článek -
16
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2‐positive and ER‐positive breast cancer patients: an explorative analysis from the NeoSphere trial Autor Tiziana Triulzi, Giampaolo Bianchini, Serena Di Cosimo, Tadeusz Pienkowski, Young‐Hyuck Im, Giulia Valeria Bianchi, Barbara Galbardi, Matteo Dugo, Loris De Cecco, Ling‐Ming Tseng, Mei‐Ching Liu, Begoña Bermejo, Vladimir Semiglazov, Giulia Viale, Juan de laHaba‐Rodriguez, Do‐Youn Oh, Brigitte Poirier, Pinuccia Valagussa, Luca Gianni, Elda Tagliabue
Vydáno 2022-06-01
Článek -
17
COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial Autor Chiara Agrati, Serena Di Cosimo, Daniela Fenoglio, Daniela Fenoglio, Giovanni Apolone, Fabio Ciceri, Gennaro Ciliberto, Fausto Baldanti, Massimo Costantini, Diana Giannarelli, Giuseppe Ippolito, Franco Locatelli, Alberto Mantovani, Alberto Mantovani, Alberto Mantovani, Aldo Morrone, Fabrizio Tagliavini, Antonio Uccelli, Antonio Uccelli, Pier Luigi Zinzani, Pier Luigi Zinzani, Nicola Silvestris, Nicola Silvestris, Maria Rescigno, Maria Rescigno
Vydáno 2021-08-01
Článek -
18
Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer Autor Serena Di Cosimo, José Manuel Pérez-García, Meritxell Bellet, Florence Dalenc, Miguel J. Gil Gil, Manuel Ruiz-Borrego, Joaquín Gavilá, Elena Aguirre, Peter Schmid, Frederik Marmé, Joseph Gligorov, Andreas Schneeweiss, Joan Albanell, Pilar Zamora, Duncan Wheatley, Eduardo Martínez de Dueñas, Kepa Amillano, Eileen Shimizu, Miguel Sampayo-Cordero, Javier Cortés, Antonio Llombart-Cussac
Vydáno 2024-08-01
Článek -
19
Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL study Autor Serena Di Cosimo, Maria Teresa Lupo-Stanghellini, Massimo Costantini, Renato Mantegazza, Fabio Ciceri, Fabio Ciceri, Carlo Salvarani, Carlo Salvarani, Pier Luigi Zinzani, Pier Luigi Zinzani, Alberto Mantovani, Alberto Mantovani, Alberto Mantovani, Gennaro Ciliberto, Antonio Uccelli, Antonio Uccelli, Fausto Baldanti, Fausto Baldanti, Giovanni Apolone, Sabina Delcuratolo, Aldo Morrone, Franco Locatelli, Franco Locatelli, Chiara Agrati, Nicola Silvestris
Vydáno 2022-10-01
Článek -
20
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials Autor Mattia Rediti, Aranzazu Fernandez-Martinez, David Venet, Françoise Rothé, Katherine A. Hoadley, Joel S. Parker, Baljit Singh, Jordan D. Campbell, Karla V. Ballman, David W. Hillman, Eric P. Winer, Sarra El-Abed, Martine Piccart, Serena Di Cosimo, William Fraser Symmans, Ian E. Krop, Roberto Salgado, Sherene Loi, Lajos Pusztai, Charles M. Perou, Lisa A. Carey, Christos Sotiriou
Vydáno 2023-11-01
Článek